Science and Technology Research Institutes

SCIOPEN RESEARCH GROUP

Open Science Open Minds

Aptos, CA

Mission

The specific purpose of this organization is to promote and facilitate research bridging basic scientific research into investigational therapeutics for amyotrophic lateral sclerosis (ALS or Motor Neurone Disease MND). ALS is an invariably fatal disease for which no United States FDA approved treatment is currently regarded as effective at changing short or longterm patient outcomes, to include slowing progression, reversing symptoms, or effectively curing a patient. The Organization will identify novel molecular entities with qualities applicable to ALS and will fund further development with the aim of delivering them into human clinical trial.

Notes from the Nonprofit

We are a new research model: "Guerrilla Biotech". We are lean, nimble, and capable. We do the unglamorous (but oh so necessary) work that others can't or won't do.

Ruling Year

2014

Executive Director

Mr. Eric Valor

Main Address

930 Wallace Ave Ste 2

Aptos, CA 95003 USA

Keywords

ALS, MND, Amyotrophic Lateral Sclerosis, Motor Neurone Disease

EIN

46-2581137

 Number

0657051178

Cause Area (NTEE Code)

(Biological, Life Science Research includes Marine Biology, Physiology, Biochemistry, Genetics, Biotechnology, etc.)) (U50)

IRS Filing Requirement

This organization is required to file an IRS Form 990-N.

Sign in or create an account to view Form(s) 990 for 2014 and 2013.
Register now

Social Media

Programs + Results

What we aim to solve New!

SciOpen Research Group is devoted to the eradication of ALS/MND (Amyotrophic Lateral Sclerosis or Motor Neurone Disease). We do the unglamorous work of testing novel molecules in pre-clinical models of ALS/MND.

Our programs

What are the organization's current programs, how do they measure success, and who do the programs serve?

SOURCE: Self-reported by organization

Anti-Necroptosis As Treatment For ALS/MND

Where we workNew!

Charting Impact

Five powerful questions that require reflection about what really matters - results.

SOURCE: Self-reported by organization

What is the organization aiming to accomplish?

What are the organization's key strategies for making this happen?

What are the organization's capabilities for doing this?

How will they know if they are making progress?

What have and haven't they accomplished so far?

Significantly-effective treatment of ALS, changing it from irreversibly fatal to a managed chronic condition with little impact on normal lifespan.

* Investigate novel and promising molecules not otherwise in research
* Develop and use novel investigation tools for research

* No brick-and-mortar office overhead allows more spending on science
* Use of independent laboratories for cost-effectiveness
* Use of "biohacker" talent for ingenuity

* Already established cooperative relationship with research laboratories and with other similar organizations devoted to ALS research * First research project (J147) complete * Second research project (fisetin+DHA) complete * Third research project (anti-necroptosis) in progress

* Already established cooperative relationship with research laboratories and with other similar organizations devoted to ALS research * First research project (J147) complete * Second research project (fisetin+DHA) complete * Third research project (anti-necroptosis) in progress

External Reviews

Financials

Sign In or Create Account to view assets data

Need more info on this nonprofit?

Need more info on this nonprofit?

FREE: Gain immediate access to the following:

  • Address, phone, website and contact information
  • Forms 990 for 2014 and 2013

Operations

The people, governance practices, and partners that make the organization tick.

Need more info?

FREE: Gain immediate access to the following:

  • Address, phone, website and contact information
  • Forms 990 for 2014 and 2013

Board Leadership Practices

GuideStar worked with BoardSource, the national leader in nonprofit board leadership and governance, to create this section, which enables organizations and donors to transparently share information about essential board leadership practices.

SOURCE: Self-reported by organization

BOARD ORIENTATION & EDUCATION

Does the board conduct a formal orientation for new board members and require all board members to sign a written agreement regarding their roles, responsibilities, and expectations?

Yes

CEO OVERSIGHT

Has the board conducted a formal, written assessment of the chief executive within the past year?

No

ETHICS & TRANSPARENCY

Have the board and senior staff reviewed the conflict-of-interest policy and completed and signed disclosure statements in the past year?

Yes

BOARD COMPOSITION

Does the board ensure an inclusive board member recruitment process that results in diversity of thought and leadership?

Yes

BOARD PERFORMANCE

Has the board conducted a formal, written self-assessment of its performance within the past three years?

No